nutriband inc. is a health and pharmaceutical company based in, oviedo, florida. nutriband's primary focus is on transdermal and topical technologies for product development.
Company profile
Ticker
NTRB
Exchange
Website
CEO
Gareth Sheridan
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Edwards Lifesciences • Avanos Medical • MSA Safety • INVACARE • Align Technology • Surgalign ...
Former names
Nutriband Inc.
SEC CIK
NTRB stock data
Latest filings (excl ownership)
10-K
2024 FY
Annual report
30 Apr 24
NT 10-K
Notice of late annual filing
30 Apr 24
8-K
Entry into a Material Definitive Agreement
23 Apr 24
8-K
Unregistered Sales of Equity Securities
28 Mar 24
8-K
Submission of Matters to a Vote of Security Holders
25 Jan 24
8-K
Regulation FD Disclosure
11 Jan 24
8-K
Unregistered Sales of Equity Securities
29 Dec 23
DEF 14A
Definitive proxy
14 Dec 23
10-Q
2024 Q3
Quarterly report
12 Dec 23
10-Q
2023 Q2
Quarterly report
8 Sep 23
Latest ownership filings
5
Gerald Goodman
25 Mar 24
5
Gerald Goodman
25 Mar 24
5
Gerald Goodman
25 Mar 24
SC 13G
MELNIK SERGUEI
13 Feb 24
SC 13G
Sheridan Gareth
12 Feb 24
SC 13D
T.I.I. - JETSERVICES, LDA
23 Jan 24
4
SERGUEI MELNIK
8 Mar 23
5/A
SERGUEI MELNIK
25 Oct 22
5/A
Gareth Sheridan
25 Oct 22
4
Gareth Sheridan
7 Jul 22
Financial summary
Quarter (USD) | Oct 23 | Jul 23 | Apr 23 | Jan 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jan 23 | Jan 22 | Jan 21 | Jan 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.27 mm | 1.27 mm | 1.27 mm | 1.27 mm | 1.27 mm | 1.27 mm |
Cash burn (monthly) | 356.41 k | 129.25 k | 586.65 k | 440.88 k | 354.76 k | 301.94 k |
Cash used (since last report) | 2.24 mm | 810.73 k | 3.68 mm | 2.77 mm | 2.23 mm | 1.89 mm |
Cash remaining | -970.30 k | 454.59 k | -2.41 mm | -1.50 mm | -959.93 k | -628.63 k |
Runway (months of cash) | -2.7 | 3.5 | -4.1 | -3.4 | -2.7 | -2.1 |
Institutional ownership, Q4 2023
12.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 11 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 3.44 mm |
Total shares | 1.35 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
T.i.i. - Jetservices, Lda | 1.35 mm | $3.44 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Oct 23 | Gerald Goodman | Stock Option Stock Option | Grant | Acquire A | No | No | 1.93 | 49,500 | 95.54 k | 192,000 |
6 Mar 23 | Serguei Melnik | Common Stock, par value $0.001 per share | Gift | Dispose G | No | No | 0 | 5,000 | 0.00 | 827,999 |
9 Dec 22 | Gerald Goodman | Stock Option Stock Option | Grant | Acquire A | No | No | 3.53 | 20,000 | 70.60 k | 142,500 |
16 Aug 22 | Gerald Goodman | Stock Option Stock Option | Grant | Acquire A | No | No | 4.09 | 23,333 | 95.43 k | 23,333 |
News
Nutriband Discloses $8.4M Private Placement Representing 2.10M Shares Of Common Stock At $4 Per Share; Company Targets 505(b)(2) NDA To FDA For Marketing Approval Of AVERSA Fentanyl In Q1 2025
19 Apr 24
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
28 Mar 24
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
27 Mar 24
12 Health Care Stocks Moving In Wednesday's Intraday Session
27 Mar 24
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
27 Mar 24
Press releases
Nutriband Inc. Announces $8.4M Private Placement
19 Apr 24
Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch
27 Mar 24
Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting
4 Mar 24